E06.3

Autoimmune thyroiditis

Autoimmune thyroiditis, most commonly recognized as Hashimoto's thyroiditis or chronic lymphocytic thyroiditis, is a chronic autoimmune disorder characterized by the immune system's production of antibodies that attack the thyroid gland. This process leads to chronic inflammation and progressive lymphocytic infiltration of the thyroid tissue, eventually resulting in the destruction of thyroid follicles and the development of primary hypothyroidism. It is the leading cause of hypothyroidism in iodine-sufficient regions. The condition typically presents with a goiter (enlarged thyroid) and is diagnosed through the presence of serum thyroid autoantibodies, specifically anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) antibodies. While the progression to overt hypothyroidism is common, some patients remain euthyroid or experience transient phases of thyrotoxicosis (hashitoxicosis) during the initial inflammatory stages.

Clinical Symptoms

  • Fatigue and lethargy
  • Weight gain despite no change in diet
  • Cold intolerance
  • Constipation
  • Dry, thickened skin
  • Hair loss or thinning
  • Brittle nails
  • Bradycardia (slow heart rate)
  • Muscle weakness and aches
  • Joint pain and stiffness
  • Depression or mood changes
  • Memory impairment (brain fog)
  • Goiter (painless thyroid enlargement)
  • Heavy or irregular menstrual periods
  • Puffy face and periorbital edema

Common Causes

  • Genetic predisposition (HLA-DR3, HLA-DR4, and HLA-DR5 alleles)
  • Presence of other autoimmune disorders (Type 1 diabetes, Celiac disease, Addison's disease)
  • Excessive iodine intake
  • Selenium deficiency
  • Infectious triggers (viral or bacterial infections)
  • Radiation exposure
  • Hormonal shifts (post-pregnancy or menopause)
  • Smoking

Documentation & Coding Tips

Distinguish between the autoimmune etiology and the functional thyroid status.

Example: Patient diagnosed with autoimmune thyroiditis (E06.3) manifesting as overt hypothyroidism (E03.9). Clinical documentation notes chronic fatigue and weight gain despite adherence to Levothyroxine 100mcg. Current TSH is 12.5 mIU/L, indicating suboptimal control of the secondary hypothyroid state.

Billing Focus: Identify E06.3 as the underlying cause while also coding the current functional state such as hypothyroidism (E03.9) or thyrotoxicosis (E05.90) to reflect total care complexity.

Document the presence and characteristics of a goiter if applicable.

Example: Examination of the neck reveals a firm, non-tender, diffuse goiter secondary to chronic lymphocytic thyroiditis (E06.3). No discrete nodules palpated; however, the thyroid is approximately 2.5 times normal size, contributing to the patient's sensation of globus.

Billing Focus: While E06.3 implies the condition, explicitly documenting a goiter supports the medical necessity for ultrasound (CPT 76536) and more complex management levels.

Specify the antibody status to reinforce the autoimmune diagnosis.

Example: Confirmed autoimmune thyroiditis (E06.3) based on highly elevated Anti-Thyroid Peroxidase (TPO) antibodies (>600 IU/mL) and Anti-Thyroglobulin (TgAb) antibodies. Patient is currently in a euthyroid phase with TSH of 2.1 mIU/L and requires monitoring every 6 months.

Billing Focus: Antibody documentation provides clinical evidence for using E06.3 rather than the more generic E06.9 (Thyroiditis, unspecified).

Capture the transient thyrotoxic phase, often referred to as Hashitoxicosis.

Example: Patient presenting with tachycardia and anxiety. Laboratory findings show suppressed TSH <0.01 mIU/L and elevated Free T4. Diagnosis is autoimmune thyroiditis with transient thyrotoxicosis (E06.2) rather than Graves disease, as confirmed by low uptake on radioactive iodine scan.

Billing Focus: Ensure E06.2 is used for the transient toxic phase of Hashimoto's instead of E06.3 to accurately reflect the acute manifestation and billing for specialized testing.

Include associated comorbidities and systemic manifestations.

Example: Patient with known autoimmune thyroiditis (E06.3) and comorbid pernicious anemia (D51.0). Documentation reflects the clinical suspicion of autoimmune polyglandular syndrome type 2. Management involves coordinated replacement of both thyroid hormone and Vitamin B12.

Billing Focus: Documentation of multiple autoimmune conditions supports high-level E/M coding (99215) due to the management of multiple stable or progressing chronic conditions.

Relevant CPT Codes

Related Diagnoses

Hierarchy